← All Posts
AUR
Aurinia Pharmaceuticals Inc.
June 04, 2026
•
Author: Phil Ratcliff
| Item |
Proposal |
Vote |
| 1 |
To elect five director nominees named in the Proxy Statement/Circular, each to serve until the 2027 annual general meeting of shareholders or until their qualified successor has been duly elected or appointed; |
|
| 1.1 |
Kevin Tang |
Withhold(1135.08)
|
| 1.2 |
Jeffrey Bailey |
✓ For(1135.08)
|
| 1.3 |
Kathy Goetz |
✓ For(1135.08)
|
| 1.4 |
Craig Johnson |
✓ For(1135.08)
|
| 1.5 |
Tina S. Nova, Ph.D. |
✓ For(1135.08)
|
| 2 |
To approve the appointment of PricewaterhouseCoopers LLP, Chartered Professional Accountants, as the Company’s independent registered public accounting firm until the close of the 2027 annual general meeting of shareholders or until a successor is appointed; |
✓ For(1135.08)
|
| 3 |
To approve, on a non-binding advisory basis, the Company’s executive compensation set forth in the Proxy Statement/Circular (the “say-on-pay” vote); |
✓ For(1135.08)
|
This article was written for information purposes only and its content should not be
construed by any consumer and/or prospective client as rebel Financial's solicitation
to affect, or attempt to affect transactions in securities, or the rendering of
personalized investment advice for compensation. No client or prospective client should
assume that any such discussion serves as the receipt of, or a substitute for,
personalized advice from rebel Financial, or from any other investment professional.
See our disclosures page for more information.
rebel Financial